Adult antiandrogens for acne are drugs that lower oil-gland signals from androgen hormones. For teens with inflammatory acne, oral spironolactone was tested in adult women only, while teen use is established for drospirenone birth-control pills and topical clascoterone.
That split matters for treatment choices. Adult trial results do not transfer directly to younger skin, dosing needs, or safety screening. Parents and teens can match each option to who was actually enrolled.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who took oral spironolactone in the SAFA trial?
- Why does FASCE still leave teens out?
- Which antiandrogen options do include teens?
- What should teens check before considering these drugs?
Who took oral spironolactone in the SAFA trial?
The SAFA phase 3 trial tested oral spironolactone in adult women only. According to the University of Southampton ePrints / BMJ 2023 record, it randomized 410 women age 18 or older with facial acne for at least 6 months that warranted oral antibiotics to spironolactone 50 mg rising to 100 mg daily versus placebo the SAFA trial record.
The group averaged 29.2 years old. About 46% had mild acne, 40% had moderate acne, and 13% had severe acne. Acne-QoL scores improved at 12 and 24 weeks.
Why does FASCE still leave teens out?
FASCE was designed to compare spironolactone with doxycycline for inflammatory lesions. The Trials via PMC protocol required at least 10 inflammatory lesions and no more than 3 nodules, but enrolled only women age at least 20 the FASCE protocol.
The protocol defined adolescent acne as under age 20. That definition placed teens outside the study by design. So results do not show how oral spironolactone works for teen inflammatory acne.
Which antiandrogen options do include teens?
Yaz contains drospirenone, a progestin with antiandrogen action, combined with estrogen. The NIH DailyMed Yaz label lists it for moderate acne vulgaris in women at least 14 years old who have reached menarche, lack contraindications, and desire oral contraception the Yaz drug label.
Clascoterone 1% cream blocks androgen receptors in skin. The NIH DailyMed Winlevi label lists it for acne vulgaris in patients 12 years and older after two phase 3 trials plus long-term safety work totaling over 1,700 patients, including teen boys and girls the Winlevi drug label.
What should teens check before considering these drugs?
Oral spironolactone has no FDA acne indication. Its NIH DailyMed label, updated in 2026, contraindicates hyperkalemia, Addison disease, and eplerenone co-use. Pregnancy use risks feminization of a male fetus, requiring contraception and excluding use in males.
At the 2026 American Academy of Dermatology meeting, Brigham and Women's acne director John Barbieri stated oral spironolactone suppresses androgen-driven sebaceous-gland activity and rivals oral antibiotics long-term, but use is effectively limited to women, as reported by Managed Healthcare Executive. The 2024 American Academy of Dermatology guidance, via Clinician Reviews, gives only conditional case-by-case recommendations for combined oral contraceptives and spironolactone, versus strong recommendations for benzoyl peroxide, retinoids, and combinations. Bring a full drug list and contraception preferences to the dermatology visit for safety screening.
- Confirm age, menarche status, and contraception need for pill options
- Review potassium, kidney, blood-pressure drugs, and Addison history for spironolactone
- Ask about benzoyl peroxide, retinoids, and combinations as first-line teen care
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: Who Was Studied and Who Was Not for Teens With Inflammatory Acne
- Limited Topical Spironolactone Evidence in the 2026 Review: Who Was Studied and Who Was Not for Teens With Inflammatory Acne
- Adult Female Acne Antiandrogen Treatments in a 2026 Review: How Teens With Inflammatory Acne Can Avoid Overreading the Headline